A Phase 2, Randomized, Double-Blind, Parallel-Group and Placebo-Controlled Pilot Study to Assess the Safety and Efficacy of a New Pain Patch Versus Placebo and No Treatment for the Treatment of Delayed Onset Muscle Soreness (DOMS)
Phase of Trial: Phase II
Latest Information Update: 30 Oct 2016
At a glance
- Drugs Loxoprofen (Primary)
- Indications Musculoskeletal pain; Pain
- Focus Therapeutic Use
- Sponsors Lead Chemical
- 14 Mar 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Dec 2015 Planned number of patients changed from 30 to 39 as reported by ClinicalTrials.gov record.
- 18 Nov 2015 New trial record